The bile–gut axis and metabolic consequences of cholecystectomy
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Andreas H Lange und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, DK-2900 Hellerup, Denmark. Hauptthemen laut MEDLINE: Bile, Fatty Liver. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Abstract (Originalsprache)
Cholelithiasis and cholecystitis affect individuals of all ages and are often treated by surgical removal of the gallbladder (cholecystectomy), which is considered a safe, low-risk procedure. Nevertheless, recent findings show that bile and its regulated storage and excretion may have important metabolic effects and that cholecystectomy is associated with several metabolic diseases postoperatively. Bile acids have long been known as emulsifiers essential to the assimilation of lipids and absorption of lipid-soluble vitamins, but more recently, they have also been reported to act as metabolic signaling agents. The nuclear receptor, farnesoid X receptor (FXR), and the G protein–coupled membrane receptor, Takeda G protein–coupled receptor 5 (TGR5), are specific to bile acids. Through activation of these receptors, bile acids control numerous metabolic functions. Cholecystectomy affects the storage and excretion of bile acids, which in turn may influence the activation of FXR and TGR5 and their effects on metabolism including processes leading to metabolic conditions such as metabolic dysfunction–associated steatotic liver disease and metabolic syndrome. Here, with the aim of elucidating mechanisms behind cholecystectomy-associated dysmetabolism, we review studies potentially linking cholecystectomy and bile acid–mediated metabolic effects and discuss possible pathophysiological mechanisms behind cholecystectomy-associated dysmetabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, DK-2900 Hellerup, Denmark.
- Department of Clinical Pharmacology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, DK-2400 Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.
- Clinical Research, Steno Diabetes Center Copenhagen, DK-2730 Herlev, Denmark.
ORCID-Profile: Filip K Knop
Zitieren
APA
Lange, A. H., Pedersen, M. G., Ellegaard, A. M., Nerild, H. H., Brønden, A., Sonne, D. P., & Knop, F. K. (2024). The bile–gut axis and metabolic consequences of cholecystectomy. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae034
Vancouver
Lange AH, Pedersen MG, Ellegaard AM, Nerild HH, Brønden A, Sonne DP, et al. The bile–gut axis and metabolic consequences of cholecystectomy. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae034
BibTeX
@article{Lange2024,
author = {Lange, Andreas H and Pedersen, Miriam G and Ellegaard, Anne-Marie and Nerild, Henriette H and Brønden, Andreas and Sonne, David P and Knop, Filip K},
title = {The bile–gut axis and metabolic consequences of cholecystectomy},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae034}
}
EUVIMED